However, the knockout of MNK gene do not affect normal cells function in mice, which suggests that targeting MNK may be an ideal therapeutic approach to selectively target cancer cells and motivates the development of drug candidates targeting MNK for cancer therapy. The gene discussed is ATP7A; the disease is cancer.